Mark W. Schwartz

Mark W. Schwartz

Président chez
MWS Strategic Advisors LLC
70 ans
Health Technology
Consumer Services
Health Services

Profil

Mark W.
Schwartz
is currently the Chairman of MWS Strategic Advisors LLC, Director of Biotechnology Innovation Organization, Director of NeoLight LLC, and Independent Director of SquareX Pharmaceuticals Corp.
He was previously the President & CEO of Bayhill Therapeutics, President, CEO & Director of Galena Biopharma, President & CEO of Apthera, President & CEO of Calyx Therapeutics, Managing Director-Life Sciences of Arizona Science & Technology Enterprises LLC, Executive Director of Targazyme, and Chief Commercial Officer of Trega Biosciences.
He also served as the COO & Executive VP of Phio Pharmaceuticals Corp.
Schwartz holds a doctorate from Arizona State University and an undergraduate degree from Grinnell College.

Postes actifs de Mark W. Schwartz

SociétésPosteDébut
Directeur/Membre du Conseil -
Directeur/Membre du Conseil 01/11/2022
Président -
Directeur/Membre du Conseil -

Anciens postes connus de Mark W. Schwartz

SociétésPosteFin
Directeur Général 31/01/2017
Arizona Science & Technology Enterprises LLC
Corporate Officer/Principal 01/01/2004
President 01/01/2003
Corporate Officer/Principal 01/01/2001
Directeur/Membre du Conseil -
Voir l'expérience en détail de Mark W. Schwartz

Formation de Mark W. Schwartz

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

70

Relations au 1er degré

14

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées14

Health Technology

Health Technology

Commercial Services

Health Technology

Consumer Services

Consumer Services

Health Services

Arizona Science & Technology Enterprises LLC

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Finance

  1. Bourse
  2. Insiders
  3. Mark W. Schwartz